Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)-Reference-Cited by-同舟云学术

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

Published:2015-01 Issue:1 Volume:6 Page:e1590-e1590
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Leverson J D,Zhang H,Chen J,Tahir S K,Phillips D C,Xue J,Nimmer P,Jin S,Smith M,Xiao Y,Kovar P,Tanaka A,Bruncko M,Sheppard G S,Wang L,Gierke S,Kategaya L,Anderson D J,Wong C,Eastham-Anderson J,Ludlam M J C,Sampath D,Fairbrother W J,Wertz I,Rosenberg S H,Tse C,Elmore S W,Souers A J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2014561.pdf

Reference70 articles.

1. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR . The BCL-2 family reunion. Mol Cell 2010; 37: 299–310.

2. Chi X, Kale J, Leber B, Andrews DW . Regulating cell death at, on, and in membranes. Biochim Biophys Acta 2014; 1843: 2100–2113.

3. Czabotar PE, Lessene G, Strasser A, Adams JM . Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49–63.

4. Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006; 9: 351–365.

5. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 2005; 435: 677–681.

Cited by 383 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric expression of Bcl-2, Mcl-1, and their ratios correlates with primary and secondary cytogenetic changes and their combinations in multiple myeloma;Annals of Hematology;2024-09-12

2. Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed;Med;2024-08

3. Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: New cues for cancer chemotherapy;Cancer Letters;2024-07

4. Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts;Scientific Reports;2024-06-19

5. Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1;Journal of Medicinal Chemistry;2024-05-02